Annual Working Group Report 2019 - Pharmaceutical Working Group Go back »

  • Published on:
  • Category:
  • by:
    Pharmaceutical Working Group / Forum
  • Keywords:


The Pharmaceutical Working Group represents approximately 35 international pharmaceutical manufacturing companies operating in China. It serves as a communication platform between the European pharmaceutical companies and Chinese authorities and regulators. The working group engages in constructive dialogue with all relevant government agencies at national, provincial and local levels and shares its expertise and international best practices with Chinese regulators. The working group encourages government policies that support the creation of a sustainable environment, which fosters innovation and the healthy growth of the pharmaceutical industry as a whole, while also improving patients’ access to affordable, innovative and high-quality medicines. The Pharmaceutical Working Group also offers recommendations based on experience accumulated during decades of healthcare reform in European countries that may further support the development of China’s healthcare system.

Related documents

Pharmaceutical Working Group Annual Report 2021

Pharmaceutical Working Group Position Paper 2021/2022 - 制药工作组建议书 2021/2022

Pharmaceutical Working Group Annual Report 2020

Related EURObiz articles